Aiforia - Medical Image Analysis Software

Certainly. But it is worth keeping in mind that the long-term financing solution just outlined is tied to Aiforia’s favorable development, which is a prerequisite. As I understand it, if the business struggles and drags its feet regarding achieving results—something there has been experience with regarding Aiforia—then the funding won’t come through, no matter how many promising contracts the company has in its folder.

3 Likes

Any financing solution that is good for the shareholders requires favorable sales development for Aiforia. If that doesn’t happen, the share will eventually go to zero. In that sense, I don’t understand how this is seen as a negative point regarding the financing… if we were to continue with share issues, in an unfavorable sales development scenario, we would soon be at a subscription price of something like 10 cents and a hundred million new shares.

2 Likes